Biologic Eases Subset of Severe Asthma – MedPage Today


MedPage Today

Biologic Eases Subset of Severe Asthma
MedPage Today
For severe eosinophilic asthma, the novel monoclonal antibody mepolizumab cut exacerbations whether given as an injection or infusion and reduced steroid use in patients dependent on them, two trials showed. The drug, which targets interleukin-5 (IL-5
A respiratory expert undermines GSK's case for new asthma drug mepolizumabFierceBiotech
Glaxo asthma drug successful in clinical trials (GSK)Seeking Alpha (registration)
GSK reports positive Phase III results of its mepolizumab in asthmaThe Pharma Letter
London South East –Business Insider
all 17 news articles »

View full post on asthma – Google News

Kimbra reveals lifelong struggle with severe asthma and dangerous attacks – Daily Mail


Daily Mail

Kimbra reveals lifelong struggle with severe asthma and dangerous attacks
Daily Mail
She's just as famous for her energetic stage performances as she is for her soaring vocals, but New Zealand singer Kimbra has revealed that she has been battling with severe asthma her entire life. The 24-year-old beauty has spoken out about her
Kimbra breathes life into asthma awareness campaignPharmacy News
Kimbra to release more Golden Echo songsThe West Australian

all 4 news articles »

View full post on asthma – Google News

AstraZeneca starts final-stage tests on severe asthma drug – Reuters


Reuters UK

AstraZeneca starts final-stage tests on severe asthma drug
Reuters
Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year. (Reporting by Ben Hirschler, Editing
AstraZeneca Starts Phase III Trial For Asthma Drug TralokinumabLondon South East
AstraZeneca Starts Late-stage Study Of Tralokinumab – Quick FactsRTT News

all 4 news articles »

View full post on asthma – Google News